Australia markets closed

Applied Therapeutics, Inc. (APLT)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
4.1500+0.0700 (+1.72%)
At close: 04:00PM EDT
4.1500 0.00 (0.00%)
After hours: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 474.21M
Enterprise value 328.07M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)6.93
Enterprise value/revenue N/A
Enterprise value/EBITDA -0.03

Trading information

Stock price history

Beta (5Y monthly) 1.91
52-week change 3221.71%
S&P500 52-week change 326.94%
52-week high 39.3900
52-week low 31.1800
50-day moving average 35.1211
200-day moving average 33.4437

Share statistics

Avg vol (3-month) 3931.53k
Avg vol (10-day) 3687.48k
Shares outstanding 5114.27M
Implied shares outstanding 6114.27M
Float 883.95M
% held by insiders 15.79%
% held by institutions 187.45%
Shares short (15 May 2024) 44.57M
Short ratio (15 May 2024) 46.13
Short % of float (15 May 2024) 44.47%
Short % of shares outstanding (15 May 2024) 44.00%
Shares short (prior month 15 Apr 2024) 44.74M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-11,101.58%

Management effectiveness

Return on assets (ttm)-51.57%
Return on equity (ttm)-612.33%

Income statement

Revenue (ttm)-477k
Revenue per share (ttm)-0.00
Quarterly revenue growth (yoy)-98.20%
Gross profit (ttm)N/A
EBITDA -74.77M
Net income avi to common (ttm)-193.56M
Diluted EPS (ttm)-1.9400
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)146.74M
Total cash per share (mrq)1.28
Total debt (mrq)343k
Total debt/equity (mrq)0.51%
Current ratio (mrq)1.80
Book value per share (mrq)0.59

Cash flow statement

Operating cash flow (ttm)-67.09M
Levered free cash flow (ttm)14.12M